findmyKOL
Clinical trialNCT05180708CompletedPhase 3Interventional

A Multicenter, Phase 3 Randomized, Double-Blind, Vehicle-Controlled Study Evaluating the Safety and Efficacy of QTORIN 3.9% Rapamycin Anhydrous Gel in the Treatment of Pachyonychia Congenita

SponsorPalvella Therapeutics, Inc.Enrollment87Pachyonychia Congenita
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This study evaluates the safety and efficacy of QTORIN 3.9% rapamycin anhydrous gel in the treatment of adults with Pachyonychia Congenita. This study includes a screening period, baseline period and 6-month treatment period.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United Kingdom
  • Royal London Hospital

    London, Whitechapel, United Kingdom

United States
  • Stanford University

    Palo Alto, California, United States

  • Yale University

    New Haven, Connecticut, United States

  • Park Avenue Dermatology

    Orange Park, Florida, United States

  • Minnesota Clinical Study Center

    Fridley, Minnesota, United States

  • Oregon Health and Sciences University

    Portland, Oregon, United States

  • Dermresearch, Inc.

    Austin, Texas, United States

  • University of Utah

    Murray, Utah, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

QTORIN 3.9% rapamycin anhydrous gelVehicle
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
29 Nov 2021
Primary completion
30 Jun 2023
Completion
30 Jun 2023
Last update posted
29 Aug 2024
Registered enrollment
87
Registry id
NCT05180708
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.